{"id":"W2293202443","doi":"10.1016/j.eururo.2016.02.030","title":"Efficacy and Safety of Mirabegron Add-on Therapy to Solifenacin in Incontinent Overactive Bladder Patients with an Inadequate Response to Initial 4-Week Solifenacin Monotherapy: A Randomised Double-blind Multicentre Phase 3B Study (BESIDE)","year":2016,"lang":"en","type":"article","venue":"European Urology","topic":"Urinary Bladder and Prostate Research","field":"Medicine","cited_by":183,"is_retracted":false,"has_abstract":true,"ca_institutions":"University of Toronto; Health Sciences Centre; Sunnybrook Health Science Centre","funders":"","keywords":"Solifenacin; Medicine; Mirabegron; Overactive bladder; Urology; Tolterodine; Urinary urgency","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002287496,0.001488786,0.004175987,0.0004783889,0.0003872516,0.001150191,0.0009505493,0.001945448,0.00435243],"category_scores_gemma":[0.002216981,0.0008438479,0.002547102,0.0004175513,0.001294827,0.001257679,0.0005295671,0.002503293,0.0006867772],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0007790327,"about_ca_system_score_gemma":0.001116951,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0006088261,"about_ca_topic_score_gemma":0.001472896,"domain_scores_codex":[0.9990273,0.0005288957,0.00008278995,0.0001561531,0.00008049425,0.0001244637],"domain_scores_gemma":[0.9983745,0.000473942,0.0004502273,0.0001450148,0.000117514,0.0004388959],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.9752195,0.007020866,0.0005427297,0.0004835761,0.0005403238,0.00002584229,0.0000510055,0.0002074114,0.004522127,0.00003294812,0.0002211689,0.01113246],"study_design_scores_gemma":[0.7882915,0.2079937,0.002213953,0.00003184338,0.0003401762,0.00004358201,0.00001906863,0.0002500597,0.0005048344,0.00004306289,0.0002481918,0.00002014308],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9958338,0.002000425,0.000176661,0.0001600564,0.0001386583,0.0009446232,0.0002890733,0.00003266825,0.0004240478],"genre_scores_gemma":[0.9930674,0.001577158,0.001283854,0.0004218083,0.0003012982,0.001890042,0.0006049389,0.00002083876,0.0008327198],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.00435243,"threshold_uncertainty_score":0.01456028,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.04777834130636659,"score_gpt":0.3576508429871424,"score_spread":0.3098725016807758,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}